Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10179820 Anti-HER2 antibodies and immunoconjugates

Patent 10179820 was granted and assigned to Genentech on January, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101798200

Patent Inventor Names

Mark X. Sliwkowski0

Xiaocheng Chen0

Gail Lewis Phillips0

Jagath Reddy Junutula0

Mark Dennis0

Thomas Harden Pillow0

Date of Patent

January 15, 2019

Patent Application Number

152964540

Date Filed

October 18, 2016

Patent Citations Received

‌

US Patent 11873330 Cysteine engineered antibodies and conjugates

‌

US Patent 10604557 Cysteine engineered antibodies and conjugates

Patent Primary Examiner

‌

Misook Yu

Patent abstract

The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10179820 Anti-HER2 antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API